Long-term use of antiplatelet drugs by patients with transient ischaemic attack

Author： Østergaard Kamilla   Madsen Charlotte   Liu Marie-Louise   Bak Søren   Hallas Jesper   Gaist David  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.70, Iss.2, 2014-02, pp. : 241-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Recognition and management of transient ischaemic attack

By Rudd Anthony   Swain Sharon   Turner Claire  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 362-363

Royal College Of Physicians

Access to resources Recommend Favorite

Use of behavioural and long-term potentiation models in the development of memory-improving drugs

By Blokland Arjan   Boess Frank  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 9, 2008-09 ,pp. : 1067-1080

Informa Healthcare

Access to resources Recommend Favorite

Non-investigational antiarrhythmic drugs: long-term use and limitations

By Gjesdal Knut  

Expert Opinion on Drug Safety, Vol. 8, Iss. 3, 2009-05 ,pp. : 345-355

Informa Healthcare

Access to resources Recommend Favorite

Atorvastatin in prevention of stroke and transient ischaemic attack

By Amarenco Pierre  

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2789-2797

Informa Healthcare

Access to resources Recommend Favorite

Diagnosis and initial management of transient ischaemic attack

By Tyrrell Pippa   Swain Sharon   Rudd Anthony  

Clinical Medicine, Vol. 10, Iss. 2, 2010-04 ,pp. : 164-167

Royal College Of Physicians

Access to resources Recommend Favorite